EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Allergy to non-steroidal anti-inflammatories in children: a narrative review of the current models of care

Annabelle Arnold, Carsten Broeze, Kate Dear, Michaela Lucas

Exploration of Asthma & Allergy · 07.06.2026 · 4

DOI: 10.37349/eaa.2026.1009128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration of Asthma & Allergy, online erschienen am 07.06.2026. Verfasst von Annabelle Arnold und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug allergies are reported in 10% of children, with non-steroidal anti-inflammatory drugs (NSAIDs) and β-lactam antibiotics being the most frequently implicated; while antibiotic allergy is more commonly reported in early childhood, NSAIDs are the leading cause of confirmed drug hypersensitivity in older children and adolescents. Paracetamol and ibuprofen are widely used in paediatrics for their analgesic, anti-pyretic, and anti-inflammatory effects via their inhibitory action on cyclooxygenase (COX) enzymes. Whilst considered generally safe, hypersensitivity reactions (HSR) to NSAIDs are the leading causes of drug-induced hypersensitivity in children and the most frequent cause of anaphylaxis. NSAID hypersensitivity is classified into immunologic (allergic) and non-immunologic (non-allergic) reactions, typically occurring in selective responders who react to a single NSAID or structurally related group without cross-intolerance. Reactions may be immediate (within one hour with urticaria, angioedema, anaphylaxis), or delayed (hours to days later). Paediatric presentations overlap with adult but pose unique diagnostic and management challenges, compounded by limited paediatric-specific evidence and variable international practice. In 2018, the European Network of Drug Allergy and the European Academy of Allergy and Clinical Immunology published a consensus-based position paper outlining recommendations for diagnosis and management in children and adolescents. A review of 12 recent paediatric studies supports current classification frameworks and reinforces oral provocation testing as the diagnostic gold standard, with prospective study designs and multicentre recruitment that enhance validity and generalisability, highlighting that cutaneous symptoms were the most common presentation and supervised graded drug challenges shown to be safe and clinically informative. Despite these advances, significant global variability persists, and current approaches are still largely guided by expert consensus rather than robust, standardised evidence. This highlights the need for internationally harmonised guidelines, large prospective studies, improved risk stratification, and the development of reliable adjunctive diagnostic tools, particularly given the limited utility and validation of skin testing in this population.

Zitieren

APA

Arnold, A., Broeze, C., Dear, K., & Lucas, M. (2026). Allergy to non-steroidal anti-inflammatories in children: a narrative review of the current models of care. Exploration of Asthma & Allergy, 4. https://doi.org/10.37349/eaa.2026.1009128

Vancouver

Arnold A, Broeze C, Dear K, Lucas M. Allergy to non-steroidal anti-inflammatories in children: a narrative review of the current models of care. Exploration of Asthma & Allergy. 2026;4. doi:10.37349/eaa.2026.1009128

BibTeX
@article{Arnold2026,
  author = {Arnold, Annabelle and Broeze, Carsten and Dear, Kate and Lucas, Michaela},
  title = {Allergy to non-steroidal anti-inflammatories in children: a narrative review of the current models of care},
  journal = {Exploration of Asthma & Allergy},
  year = {2026},
  volume = {4},
  doi = {10.37349/eaa.2026.1009128}
}
Kostenlos starten →